Armata Pharmaceuticals Inc (ARMP)
2.40
-0.15
(-5.88%)
USD |
NYAM |
May 01, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Armata Pharmaceuticals Cash from Operations (TTM): -47.42M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.42M |
| September 30, 2023 | -49.80M |
| June 30, 2023 | -50.45M |
| March 31, 2023 | -46.54M |
| December 31, 2022 | -32.48M |
| September 30, 2022 | -30.59M |
| June 30, 2022 | -25.22M |
| March 31, 2022 | -21.62M |
| December 31, 2021 | -23.58M |
| September 30, 2021 | -21.28M |
| June 30, 2021 | -20.20M |
| March 31, 2021 | -19.51M |
| December 31, 2020 | -18.27M |
| September 30, 2020 | -14.70M |
| June 30, 2020 | -15.38M |
| March 31, 2020 | -17.36M |
| December 31, 2019 | -15.58M |
| September 30, 2019 | -14.80M |
| June 30, 2019 | -11.96M |
| March 31, 2019 | -8.305M |
| December 31, 2018 | -9.382M |
| September 30, 2018 | -9.801M |
| June 30, 2018 | -8.671M |
| March 31, 2018 | -9.429M |
| December 31, 2017 | -9.192M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.321M |
| June 30, 2017 | -10.86M |
| March 31, 2017 | -10.82M |
| December 31, 2016 | -10.61M |
| September 30, 2016 | -11.42M |
| June 30, 2016 | -10.79M |
| March 31, 2016 | -10.56M |
| December 31, 2015 | -9.781M |
| September 30, 2015 | -10.66M |
| June 30, 2015 | -10.79M |
| March 31, 2015 | -11.19M |
| December 31, 2014 | -12.57M |
| September 30, 2014 | -10.78M |
| June 30, 2014 | -10.65M |
| March 31, 2014 | -8.864M |
| December 31, 2013 | -6.292M |
| September 30, 2013 | -3.633M |
| June 30, 2013 | -2.581M |
| March 31, 2013 | -2.608M |
| September 30, 2009 | -5.357M |
| June 30, 2009 | -9.831M |
| March 31, 2009 | -8.054M |
| December 31, 2008 | -10.30M |
| September 30, 2008 | -10.14M |
| June 30, 2008 | -11.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-50.45M
Minimum
Jun 2023
-11.96M
Maximum
Jun 2019
-26.14M
Average
-21.28M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Xtant Medical Holdings Inc | -9.515M |